UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Lowered by 1834 Investment Advisors Co.

1834 Investment Advisors Co. trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 14.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,256 shares of the healthcare conglomerate’s stock after selling 1,861 shares during the quarter. 1834 Investment Advisors Co.’s holdings in UnitedHealth Group were worth $6,581,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in UNH. Tealwood Asset Management Inc. acquired a new position in UnitedHealth Group in the third quarter worth approximately $2,905,000. Asset Planning Services Inc. LA ADV boosted its position in shares of UnitedHealth Group by 1.2% in the 3rd quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock valued at $7,288,000 after purchasing an additional 150 shares during the period. Sequoia Financial Advisors LLC boosted its holdings in shares of UnitedHealth Group by 13.7% in the third quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock worth $14,603,000 after buying an additional 3,006 shares during the period. Americana Partners LLC lifted its holdings in shares of UnitedHealth Group by 10.8% in the third quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate’s stock valued at $11,914,000 after purchasing an additional 1,984 shares in the last quarter. Finally, Concord Investment Counsel Inc. acquired a new stake in UnitedHealth Group during the 1st quarter worth about $14,544,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Up 1.6 %

Shares of UNH stock opened at $566.96 on Wednesday. The firm’s 50-day moving average is $580.96 and its 200-day moving average is $543.36. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. The stock has a market cap of $523.54 billion, a price-to-earnings ratio of 36.94, a PEG ratio of 1.64 and a beta of 0.58. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $608.63.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the prior year, the business posted $6.56 earnings per share. UnitedHealth Group’s revenue was up 9.2% compared to the same quarter last year. Sell-side analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.48%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 24th. Barclays lowered their price objective on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and lifted their price target for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. Stephens reduced their target price on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Finally, Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.